Critical review of acylation-stimulating protein physiology in humans and rodents - PubMed (original) (raw)
Review
. 2003 Jan 31;1609(2):127-43.
doi: 10.1016/s0005-2736(02)00686-7.
Affiliations
- PMID: 12543373
- DOI: 10.1016/s0005-2736(02)00686-7
Free article
Review
Critical review of acylation-stimulating protein physiology in humans and rodents
Katherine Cianflone et al. Biochim Biophys Acta. 2003.
Free article
Abstract
In the last few years, there has been increasing interest in the physiological role of acylation-stimulating protein (ASP). Recent studies in rats and mice, in particular in C3 (-/-) mice that are ASP deficient, have advanced our understanding of the role of ASP. Of note, the background strain of the mice influences the phenotype of delayed postprandial triglyceride clearance in ASP-deficient mice. Administration of ASP in all types of lean and obese mice studied to date, however, enhances postprandial triglyceride clearance. On the other hand, regardless of the background strain, ASP-deficient mice demonstrate reduced body weight, reduced leptin and reduced adipose tissue mass, suggesting that ASP deficiency results in protection against development of obesity. In humans, a number of studies have examined the relationship between ASP, obesity, diabetes and dyslipidemia as well as the influence of diet, exercise and pharmacological therapy. While many of these studies have small subject numbers, interesting observations may help us to better understand the parameters that may influence ASP production and ASP action. The aim of the present review is to provide a comprehensive overview of the recent literature on ASP, with particular emphasis on those studies carried out in rodents and humans.
Similar articles
- Regulation of alternative pathway activation and C3a production by adipose cells.
Choy LN, Spiegelman BM. Choy LN, et al. Obes Res. 1996 Nov;4(6):521-32. doi: 10.1002/j.1550-8528.1996.tb00266.x. Obes Res. 1996. PMID: 8946437 - Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein.
Murray I, Havel PJ, Sniderman AD, Cianflone K. Murray I, et al. Endocrinology. 2000 Mar;141(3):1041-9. doi: 10.1210/endo.141.3.7364. Endocrinology. 2000. PMID: 10698180 - The acylation stimulating protein-adipsin system.
Cianflone K, Maslowska M, Sniderman A. Cianflone K, et al. Int J Obes Relat Metab Disord. 1995 May;19 Suppl 1:S34-8. Int J Obes Relat Metab Disord. 1995. PMID: 7550536 Review. - Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.
Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA, Ebeling P. Koistinen HA, et al. Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):1034-9. doi: 10.1161/01.atv.21.6.1034. Arterioscler Thromb Vasc Biol. 2001. PMID: 11397716 - Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.
Cianflone K, Maslowska M, Sniderman AD. Cianflone K, et al. Semin Cell Dev Biol. 1999 Feb;10(1):31-41. doi: 10.1006/scdb.1998.0272. Semin Cell Dev Biol. 1999. PMID: 10355026 Review.
Cited by
- Complement C3: an emerging risk factor in cardiometabolic disease.
Hertle E, van Greevenbroek MM, Stehouwer CD. Hertle E, et al. Diabetologia. 2012 Apr;55(4):881-4. doi: 10.1007/s00125-012-2462-z. Epub 2012 Jan 27. Diabetologia. 2012. PMID: 22282163 Free PMC article. - Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study.
Engström G, Hedblad B, Janzon L, Lindgärde F. Engström G, et al. Diabetologia. 2005 Dec;48(12):2525-31. doi: 10.1007/s00125-005-0021-6. Epub 2005 Nov 11. Diabetologia. 2005. PMID: 16283247 - Plasma Levels of Acylation-Stimulating Protein Are Strongly Predicted by Waist/Hip Ratio and Correlate with Decreased LDL Size in Men.
Saleh J, Wahab RA, Farhan H, Al-Amri I, Cianflone K. Saleh J, et al. ISRN Obes. 2013 Feb 12;2013:342802. doi: 10.1155/2013/342802. eCollection 2013. ISRN Obes. 2013. PMID: 24533222 Free PMC article. - IgG is elevated in obese white adipose tissue but does not induce glucose intolerance via Fcγ-receptor or complement.
van Dam AD, van Beek L, Pronk ACM, van den Berg SM, Van den Bossche J, de Winther MPJ, Koning F, van Kooten C, Rensen PCN, Boon MR, Verbeek JS, van Dijk KW, van Harmelen V. van Dam AD, et al. Int J Obes (Lond). 2018 Feb;42(2):260-269. doi: 10.1038/ijo.2017.209. Epub 2017 Aug 30. Int J Obes (Lond). 2018. PMID: 28852207 - Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.
Roberts CK, Hevener AL, Barnard RJ. Roberts CK, et al. Compr Physiol. 2013 Jan;3(1):1-58. doi: 10.1002/cphy.c110062. Compr Physiol. 2013. PMID: 23720280 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous